TipRanks
Go Ultimate55% OFF

Merck & Company (6MK) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

6MK Analyst Ratings

Moderate Buy
21Ratings
15Buy6Hold0Sell
Based on 21 analysts giving stock ratings to Merck & Company in the past 3 months

6MK Stock 12 Month Forecast

CHF 132.68â–²(37.39% Upside)
Based on 21 Wall Street analysts offering 12 month price targets for Merck & Company in the last 3 months. The average price target is CHF 132.68 with a high forecast of CHF 147.73 and a low forecast of CHF 86.18. The average price target represents a 37.39% change from the last price of CHF 96.58.
Highest Price TargetCHF 147.73Average Price TargetCHF 132.68Lowest Price TargetCHF 86.18

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:6MK
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
ScotiabankCHF 147.73buy52.96%UpsideAssigned10/30/26
Bank of America SecuritiesCHF 133.78→CHF 135.42buy40.22%UpsideReiterated10/30/26
BMO CapitalCHF 139.52buy44.47%UpsideReiterated10/30/26
Morgan StanleyCHF 145.27→CHF 142.81buy47.87%UpsideAssigned10/30/26
J.P. MorganCHF 135.42→CHF 143.63buy48.72%UpsideAssigned10/30/26
GuggenheimCHF 139.52→CHF 140.34buy45.32%UpsideReiterated10/29/26
BarclaysCHF 147.73buy52.96%UpsideReiterated10/28/26
CitiCHF 119.01hold23.22%UpsideReiterated10/27/26
RBC CapitalCHF 119.01hold23.22%UpsideReiterated10/27/26
Wells FargoCHF 135.42buy40.22%UpsideReiterated10/26/26
Cantor FitzgeraldCHF 119.01hold23.22%UpsideReiterated10/26/26
BernsteinCHF 86.18hold-10.77%DownsideReiterated10/25/26
UBSCHF 143.63buy48.72%UpsideReiterated10/24/26
Goldman SachsCHF 127.21buy31.72%UpsideReiterated10/22/26
Leerink PartnersCHF 132.14buy36.82%UpsideReiterated10/12/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Merck & Company

3 Months
Asad Haider
Asad HaiderGoldman Sachs
Success Rate14/15 ratings generated profit
93%
Average Return
+10.04%

Copying Asad Haider's trades and holding each position for 3 Months would result in 93.33% of your transactions generating a profit, with an average return of +10.04% per trade.

1 Year
Asad Haider
Asad HaiderGoldman Sachs
Success Rate15/15 ratings generated profit
100%
Average Return
+34.91%

Copying Asad Haider's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +34.91% per trade.

2 Years
Asad Haider
Asad HaiderGoldman Sachs
Success Rate15/15 ratings generated profit
100%
Average Return
+41.54%

Copying Asad Haider's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.54% per trade.

6MK Analyst Recommendation Trends

050100150200Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 6MK
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy10000
Buy4344525464
Hold1816161723
Sell00000
Strong Sell00000
total6260687187

In the current month, 6MK has received 64 Buy Ratings, 23 Hold Ratings, and 0 Sell Ratings. 6MK average Analyst price target in the past 3 months is 132.68.

6MK Financial Forecast

CHF -3CHF -1.5CHF 0CHF 1.5CHF 3Q1 2026Q3 2026Q4 2026
HighCHF 1.62
ConsensusCHF 1.48
LowCHF 1.41

6MK Earnings Forecast

Next quarter’s earnings estimate for 6MK is CHF 1.48 with a range of CHF 1.41 to CHF 1.62. The previous quarter’s EPS was CHF 2.05. 6MK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 6MK has Performed in-line its overall industry.

CHF 13.1BCHF 13.6BCHF 14BCHF 14.5BCHF 14.9BQ1 2026Q3 2026Q4 2026
HighCHF 13.8B
ConsensusCHF 13.5B
LowCHF 13.1B

6MK Sales Forecast

Next quarter’s sales forecast for 6MK is CHF 13.49B with a range of CHF 13.11B to CHF 13.81B. The previous quarter’s sales results were CHF 14.90B. 6MK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 6MK has Performed in-line its overall industry.

6MK Stock Forecast FAQ

What is CH:6MK’s average 12-month price target, according to analysts?
Based on analyst ratings, Merck & Company’s 12-month average price target is CHF132.68.
What is CH:6MK’s upside potential, based on the analysts’ average price target?
Merck & Company has 37.39% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Merck & Company a Buy, Sell or Hold?
Merck & Company has a consensus rating of Moderate Buy, which is based on 15 buy ratings, 6 hold ratings and 0 sell ratings.
What is Merck & Company’s share price target?
The average share price target for Merck & Company is CHF132.68. This is based on 21 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF147.73, and the lowest forecast is CHF86.18. The average share price target represents a 37.39% increase from the current price of CHF96.578.
What do analysts say about Merck & Company?
Merck & Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Street analysts.
How can I buy shares of Merck & Company?
To buy shares of CH:6MK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.